Inorganic pyrophosphate (PP,) levels were estimated by radiometric assay in urine and in synovial fluid (SF) froim asymptomatic, nonarthritic knees of patients with iuntreated metabolic disease and normal controls. SF F'P, was significantly elevated in patients with hyperparathyroidism (mean f SEM 19 k 3 pM; n = 9), hemochromatosis (23 f 5 pM; n = 6), and hypomagnesemia (27 f 0.1 pM; n = 2) compared with normal subjec1.s (10 f 0.5 pM, n = 50), and was low in patients with hypothyroidism (4.2 f 2.3 pM; n = 11) (P < 0.05 all comparisons). Urinary PP, was elevated only in those with hypophosphatasia. Local elevation of ionic PP, may be relevant to the mechanism of crystal formation in metabolic diseases predisposing to calcium pyrophosphate dihydrate (CPPD) crystal deposition. The finding of low SF PP, levels in patients with hypothyroidism further questions the association between this condition and CPPD.Factors recognized as predisposing to chondrocalcinosis due to calcium pyrophosphate dihydrate (CPPD) crystal deposition include aging (M), the osteoarthritis process (2-7), a familial predisposition (1,7-12), and associated metabolic disease (I ,7,13). In